Related Experiment Videos
[Controversies in the secondary prevention of stroke]
Revue Medicale De Liege
|August 28, 2003
Insights
Stroke is a leading cause of death and disability. Prompt evaluation for treatable causes and antiplatelet medication are crucial after a transient ischemic attack or minor stroke to prevent recurrence.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Public Health
Context:
- Stroke is a major cause of mortality and long-term disability globally.
- Recurrence risk after a transient ischemic attack (TIA) or minor stroke is significantly elevated (16-fold).
Purpose:
- To emphasize the critical need for prompt etiological investigation in patients with suspected first ischemic cerebral events.
- To highlight the importance of initiating appropriate treatment, including antiplatelet therapy, when specific causes are not identified.
Summary:
- Patients experiencing a potential first ischemic stroke require thorough evaluation to identify underlying treatable causes.
- If no specific cause is found, initiating antiplatelet medication is recommended to mitigate the high risk of recurrent events.
Impact:
- Early diagnosis and treatment can significantly reduce the risk of stroke recurrence and long-term disability.
- Implementing standardized diagnostic and therapeutic protocols can improve patient outcomes and reduce healthcare burdens associated with stroke.
Abstract:
Stroke is the third leading cause of death and the main cause of prolonged disability of adults in industrialised countries. After a first transient ischemic attack or a first minor stroke, the risk of recurrence is 16 folds higher than in control subjects. Therefore each patient suspect of a first ischemic cerebral event should be evaluated for the presence of a specific cause which could be treated. If such a cause is not found, platelet antiaggregant medications should be started.